Filing Details
- Accession Number:
- 0001415889-24-000952
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-10 19:14:52
- Reporting Period:
- 2024-01-08
- Accepted Time:
- 2024-01-10 19:14:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1644557 | William Thomas Burns | C/O Glaukos Corporation One Glaukos Way Aliso Viejo CA 92656 | Chairman & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-01-08 | 60,000 | $7.28 | 115,835 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-01-08 | 2,314 | $80.65 | 113,521 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-08 | 12,614 | $81.50 | 100,907 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-08 | 23,299 | $82.38 | 77,608 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-08 | 17,873 | $83.38 | 59,735 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-08 | 3,900 | $84.21 | 55,835 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-01-09 | 115 | $7.28 | 55,950 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-01-09 | 5 | $85.00 | 55,945 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-09 | 73 | $86.74 | 55,872 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-09 | 37 | $87.33 | 55,835 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-01-08 | 60,000 | $0.00 | 60,000 | $7.28 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-01-09 | 115 | $0.00 | 115 | $7.28 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
115 | 2024-07-10 | No | 4 | M | Direct | |
0 | 2024-07-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 893,932 | Indirect | Through the Burns Family Trust |
Common Stock | 238,107 | Indirect | Through the Burns Annuity Trust |
Common Stock | 120,000 | Indirect | Through the Burns Charitable Remainder Trust |
Common Stock | 100,000 | Indirect | Through the Thomas W. Burns Irrevocable Trust |
Common Stock | 100,000 | Indirect | Through the Janet M. Burns Irrevocable Trust |
Footnotes
- Includes 47,177 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023.
- This transaction was executed in multiple trades at prices ranging from $80.00 to $80.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $81.00 to $81.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $82.00 to $82.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $83.00 to $83.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $84.05 to $84.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $86.25 to $87.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $87.26 to $88.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023.
- This option was granted on July 10, 2014 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and theremainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grantdate.